Authors:
Galbraith, SM
Chaplin, DJ
Lee, F
Stratford, MRL
Locke, RJ
Vojnovic, B
Tozer, GM
Citation: Sm. Galbraith et al., Effects of combretastatin A4 phosphate on endothelial cell morphology in vitro and relationship to tumour vascular targeting activity in vivo, ANTICANC R, 21(1A), 2001, pp. 93-102
Authors:
Seddon, BM
Honess, DJ
Vojnovic, B
Tozer, GM
Workman, P
Citation: Bm. Seddon et al., Measurement of tumor oxygenation: In vivo comparison of a luminescence fiber-optic sensor and a polarographic electrode in the P22 tumor, RADIAT RES, 155(6), 2001, pp. 837-846
Authors:
Tozer, GM
Prise, VE
Wilson, J
Cemazar, M
Shan, SQ
Dewhirst, MW
Barber, PR
Vojnovic, B
Chaplin, DJ
Citation: Gm. Tozer et al., Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: Intravital microscopy and measurement of vascular permeability, CANCER RES, 61(17), 2001, pp. 6413-6422
Authors:
Coralli, C
Cemazar, M
Kanthou, C
Tozer, GM
Dachs, GU
Citation: C. Coralli et al., Limitations of the reporter green fluorescent protein under simulated tumor conditions, CANCER RES, 61(12), 2001, pp. 4784-4790
Authors:
Cemazar, M
Parkins, CS
Holder, AL
Chaplin, DJ
Tozer, GM
Sersa, G
Citation: M. Cemazar et al., Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy, BR J CANC, 84(4), 2001, pp. 565-570
Authors:
Greco, O
Folkes, LK
Wardman, P
Tozer, GM
Dachs, GU
Citation: O. Greco et al., Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid, CANC GENE T, 7(11), 2000, pp. 1414-1420
Authors:
Bell, KM
Chaplin, DJ
Poole, BA
Prise, VE
Tozer, GM
Citation: Km. Bell et al., Modification of blood flow in the HSN tumour and normal tissues of the ratby the endothelin ETB receptor agonist, IRL 1620, INT J CANC, 80(2), 1999, pp. 295-302
Authors:
Tozer, GM
Prise, VE
Wilson, J
Locke, RJ
Vojnovic, B
Stratford, MRL
Dennis, MF
Chaplin, DJ
Citation: Gm. Tozer et al., Combretastatin A-4 phosphate as a tumor vascular-targeting agent: Early effects in tumors and normal tissues, CANCER RES, 59(7), 1999, pp. 1626-1634